Celularity Inc CELU:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:58 AM EDT
3.49quote price arrow down-0.15 (-4.12%)
Volume
21,774
52 week range
1.59 - 8.90
Loading...
  • Open3.72
  • Day High3.82
  • Day Low3.43
  • Prev Close3.64
  • 52 Week High8.90
  • 52 Week High Date06/14/23
  • 52 Week Low1.59
  • 52 Week Low Date12/27/23

Key Stats

  • Market Cap76.022M
  • Shares Out21.78M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.47
  • YTD % Change40.26

KEY STATS

  • Open3.72
  • Day High3.82
  • Day Low3.43
  • Prev Close3.64
  • 52 Week High8.90
  • 52 Week High Date06/14/23
  • 52 Week Low1.59
  • 52 Week Low Date12/27/23
  • Market Cap76.022M
  • Shares Out21.78M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.47
  • YTD % Change40.26

RATIOS/PROFITABILITY

  • EPS (TTM)-10.51
  • P/E (TTM)-0.33
  • Fwd P/E (NTM)-6.02
  • EBITDA (TTM)45.107M
  • ROE (TTM)-186.56%
  • Revenue (TTM)14.788M
  • Gross Margin (TTM)21.19%
  • Net Margin (TTM)-1,226.72%
  • Debt To Equity (MRQ)115.73%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Celularity Inc

 

Profile

MORE
Celularity Inc. is a clinical-stage biotechnology company. The Company is engaged in developing off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through three business segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapy product candidates include T cells engineered with a chimeric antigen receptor (CAR), natural killer, cells, mesenchymal-like adherent stromal cells...
Robert Hariri M.D., Ph.D.
Chairman of the Board, Chief Executive Officer
David Beers
Chief Financial Officer
John Haines
Senior Executive Vice President, Chief Administrative Officer, General Manager
Address
170 Park Ave
Florham Park, NJ
07932
United States

Top Peers

SYMBOLLASTCHG%CHG
GRTS
Gritstone bio Inc
0.7618+0.0005+0.0657%
CRIS
Curis Inc
14.74-0.95-6.06%
CARM
Carisma Therapeutics Inc
1.45-0.01-0.68%
JAGX
Jaguar Health Inc
0.267-0.0079-2.8738%
AFMD
Affimed NV
5.22-0.02-0.38%